These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 21917484)
1. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures. García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484 [TBL] [Abstract][Full Text] [Related]
2. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
3. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy. Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195 [TBL] [Abstract][Full Text] [Related]
5. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T; Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227 [TBL] [Abstract][Full Text] [Related]
6. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial. Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S; Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation. Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854 [TBL] [Abstract][Full Text] [Related]
8. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study. Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635 [TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628 [TBL] [Abstract][Full Text] [Related]
11. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Guilhoto LM; Loddenkemper T; Gooty VD; Rotenberg A; Takeoka M; Duffy FH; Coulter D; Urion D; Bourgeois BF; Kothare SV Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [TBL] [Abstract][Full Text] [Related]
14. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients. Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center. Kurth C; Kockelmann E; Steinhoff BJ Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111 [TBL] [Abstract][Full Text] [Related]
17. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy. Pasha I; Kamate M; Didagi SK Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy. Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718 [TBL] [Abstract][Full Text] [Related]